Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IXICO plc ( (GB:IXI) ) just unveiled an update.
IXICO plc has launched a retail offer in the UK for up to 6.25 million new ordinary shares at 8 pence each via the BookBuild platform, alongside previously announced placings and a subscription that together aim to raise £10 million before expenses. Assuming full take-up of the retail tranche, the broader fundraising could total £10.5 million, with the offer structured specifically to allow existing UK retail shareholders to participate on terms slightly above the latest closing market price.
The retail offer, which runs from 31 March to 7 April 2026 and is coordinated by Cavendish Capital Markets, is not conditional on the institutional placings or subscription and is limited to existing UK shareholders acting through participating intermediaries. Net proceeds from the first placing and any retail subscriptions will be directed towards platform automation, further differentiation of IXICO’s analysis pipelines, and investment in corporate development, commercial staff, KOL consultancy and marketing, signalling a push to enhance its technology capabilities and strengthen its commercial footprint.
The most recent analyst rating on (GB:IXI) stock is a Hold with a £7.50 price target. To see the full list of analyst forecasts on IXICO plc stock, see the GB:IXI Stock Forecast page.
Spark’s Take on IXI Stock
According to Spark, TipRanks’ AI Analyst, IXI is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and negative operating cash flow) and very bearish technicals (below key moving averages with negative MACD). A positive offset comes from supportive earnings-call guidance and order book growth, but valuation remains constrained by the company’s loss-making profile.
To see Spark’s full report on IXI stock, click here.
More about IXICO plc
IXICO plc is a UK-based company operating in the life sciences and clinical research technology sector, focused on advanced neuroimaging and AI-driven data analysis. It provides specialised imaging analysis services and technology platforms to pharmaceutical and biotech clients, with an emphasis on neurological diseases and clinical trial support.
Average Trading Volume: 133,205
Technical Sentiment Signal: Sell
Current Market Cap: £7.3M
For detailed information about IXI stock, go to TipRanks’ Stock Analysis page.